Li Yong, Furniss Jonathan A, Vautrinot Jordan, Williams Christopher M, Walsh Tony G, Brill Alexander, Amulic Borko, Poole Alastair W
School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
J Thromb Haemost. 2025 Jan;23(1):254-261. doi: 10.1016/j.jtha.2024.10.010. Epub 2024 Oct 24.
Deep vein thrombosis is a major cause of morbidity and mortality globally. While its pathophysiology is complex, increasing evidence suggests a more prominent role for platelets than previously suspected. Genetic deletion of Ral GTPases, RalA and RalB, conditionally in mouse platelets (RalAB double knockout [DKO]), results in a near complete defect in P-selectin externalization upon activation, while other platelet activation responses and arterial thrombosis are preserved.
Given the critical role of P-selectin in mediating platelet-neutrophil interaction and thromboinflammation, we sought to investigate whether platelet Rals would also play critical roles in venous thrombosis, a thromboinflammatory disease, using RalAB DKO mice.
Deep vein thrombosis was induced by surgical partial ligation of the caudal (inferior) vena cava for 24 hours or 48 hours before venous thrombi were assessed by histology and immunofluorescence microscopy.
RalAB DKO mice showed a reduction in venous thrombus formation after 24 hours and near complete ablation of venous thrombosis by 48 hours post inferior vena cava ligation. Immunofluorescence microscopy revealed that cross-sections of thrombi from wild-type mice consisted of an organized scaffolded structure of platelets surrounding leukocytes/neutrophils producing neutrophil extracellular traps (NETs) to stabilize and propagate the thrombus. This organized structure was absent in platelet-specific conditional RalAB DKO thrombi. In vitro analysis of platelet-mediated NET formation was also significantly reduced when platelets lacked RalAB or when platelets were treated with the Ral inhibitor RBC8.
We identify platelet Rals as novel, potentially critical regulators of venous thrombus stability through their ability to regulate neutrophil NET formation via platelet P-selectin.
深静脉血栓形成是全球发病和死亡的主要原因。虽然其病理生理学很复杂,但越来越多的证据表明血小板的作用比以前认为的更为突出。在小鼠血小板中条件性地基因敲除Ral GTP酶RalA和RalB(RalAB双敲除[DKO]),导致激活时P-选择素外化几乎完全缺陷,而其他血小板激活反应和动脉血栓形成得以保留。
鉴于P-选择素在介导血小板-中性粒细胞相互作用和血栓炎症中起关键作用,我们试图使用RalAB DKO小鼠研究血小板Ral在静脉血栓形成(一种血栓炎症性疾病)中是否也起关键作用。
通过手术部分结扎尾(下)腔静脉24小时或48小时诱导深静脉血栓形成,然后通过组织学和免疫荧光显微镜评估静脉血栓。
RalAB DKO小鼠在24小时后静脉血栓形成减少,在下腔静脉结扎后48小时静脉血栓形成几乎完全消失。免疫荧光显微镜显示,野生型小鼠血栓横断面由围绕产生中性粒细胞胞外诱捕网(NETs)的白细胞/中性粒细胞的有组织的血小板支架结构组成,以稳定和传播血栓。这种有组织的结构在血小板特异性条件性RalAB DKO血栓中不存在。当血小板缺乏RalAB或用Ral抑制剂RBC8处理血小板时,血小板介导的NET形成的体外分析也显著减少。
我们确定血小板Ral是静脉血栓稳定性的新型潜在关键调节因子,通过其调节血小板P-选择素介导的中性粒细胞NET形成的能力。